國立虎尾科技大學 |

Neuroimaging Pharmacopoeia

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Neuroimaging Pharmacopoeia/ edited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer.
其他作者:	Schaefer, Pamela Whitney.
面頁冊數:	IX, 448 p. 365 illus., 30 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Pharmacology. -
電子資源:	https://doi.org/10.1007/978-3-031-08774-5
ISBN:	9783031087745

Neuroimaging Pharmacopoeia
Neuroimaging Pharmacopoeia[electronic resource] /edited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer. - 2nd ed. 2022. - IX, 448 p. 365 illus., 30 illus. in color.online resource.

PART I: Drugs and Alcohol -- 1. Tobacco -- 2. Alcohol -- 3. Methanol -- 4. Cannabis (Marijuana) -- 5. Synthetic Cannabinoids (spice/K2 preparations) -- 6. Crack and Cocaine -- 7. Amphetamines -- 8. Opioids -- 9. Betel Nuts -- 10. Licorice -- 11. Centella asiatica -- PART II: Contrast Agents -- 12. Iodinated Contrast Agents -- 13. Gadolinium-Based Contrast Agents -- 14. Ferumoxytol -- 15. Pantopaque (Myodil, Iodophenylundecylic Acid) -- 16. Thorium Dioxide (Thorotrast) -- PART III: Chemotherapy -- 17. Temozolamide (Temodar) -- 18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) -- 19. Methotrexate -- 20. 5-Fluorouracil -- 21. L-Asparaginase (Elspar/Erwinase) -- 22. Calcineurin Inhibitors -- 23. Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) -- PART IV: Anti-cancer Immunotherapy -- 25. Ipilimumab (MDX-010, Yervoy) -- 26. Bevacizumab (Avastin) -- 27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) -- PART V: Antiobiotics, Antiviral Agents, and Vaccines -- 28. Metronidazole (Flagyl) -- 29. Iodoform -- 30. Isoniazid -- 31. Highly Active Antiretroviral Therapy (HAART) -- 32. Vaccines -- PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents -- 33. Dilantin (Phenytoin Sodium) -- 34. Valproic Acid (Sodium Valproate, Depakote) -- 35. Vigabatrin (Sabril) -- 36. Lithium -- 37. Neuroleptics -- PART VII: Anesthetic and Sedative Agents -- 38. Barbiturates (Pentobarbital) -- 39. Nitrous Oxide (N2O) -- 40. Propofol -- PART VIII: Hemostatic and Vasoactive Agents -- 41. Embolic Agents -- 42. Aspirin and Plavix/Clopidogrel -- 43. Warfarin (Coumadin) -- 44. Heparin -- 45. Tissue Plasminogen Activator (tPA) -- 46. Oxidized Cellulose -- 47. Nasal Decongestants -- PART IX: Cardiovascular Support Agents -- 48. Supplemental Oxygen -- 49. Hypertonic Saline -- 50. Mannitol (1,2,3,4,5,6-Hexanehexol) -- 51. Triple H Therapy -- 52. Angiotensin Converting Enzyme (ACE) Inhibitors -- 53. Acetazolamide (Diamox) -- 54. Amiodarone -- PART X: Anti-inflammatory Agents -- 55. Acetominophen (Tylenol, Paracetamol) -- 56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals) -- 57. Synthetic Corticosteroids -- PART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs -- 58. Manganese in Total Parenteral Nutrition -- 59. Zinc Oxide (ZnO) -- 60. Insulin -- 61. Bisphosphonates -- 62. Recombinant Human Bone Morphogenetic Protein -- 63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid) -- 64. Topical Prostaglandin Analogues -- 65. Oral Contraceptives (Estrogen and Progestin) -- 66. Fish Oil -- PART XII: Injectable Filler Agents -- 67. Calcium hydroxyapatite-based Fillers -- 68. Hyaluronic Acid-based Fillers -- 69. Injectable Silicone Oil.

This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book’s closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike. .

ISBN: 9783031087745

Standard No.: 10.1007/978-3-031-08774-5doiSubjects--Topical Terms:

583819
Pharmacology.

LC Class. No.: R895-920

Dewey Class. No.: 616.0757

Neuroimaging Pharmacopoeia
LDR:05113nam a22003975i 4500 001 1085979
003 DE-He213
005 20221129152348.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783031087745 $9 978-3-031-08774-5
024 7 $a 10.1007/978-3-031-08774-5 $2 doi
035 $a 978-3-031-08774-5
050 4 $a R895-920
072 7 $a MMP $2 bicssc
072 7 $a MED056000 $2 bisacsh
072 7 $a MKS $2 thema
082 0 4 $a 616.0757 $2 23
245 1 0 $a Neuroimaging Pharmacopoeia $h [electronic resource] / $c edited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer.
250 $a 2nd ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a IX, 448 p. 365 illus., 30 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a PART I: Drugs and Alcohol -- 1. Tobacco -- 2. Alcohol -- 3. Methanol -- 4. Cannabis (Marijuana) -- 5. Synthetic Cannabinoids (spice/K2 preparations) -- 6. Crack and Cocaine -- 7. Amphetamines -- 8. Opioids -- 9. Betel Nuts -- 10. Licorice -- 11. Centella asiatica -- PART II: Contrast Agents -- 12. Iodinated Contrast Agents -- 13. Gadolinium-Based Contrast Agents -- 14. Ferumoxytol -- 15. Pantopaque (Myodil, Iodophenylundecylic Acid) -- 16. Thorium Dioxide (Thorotrast) -- PART III: Chemotherapy -- 17. Temozolamide (Temodar) -- 18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) -- 19. Methotrexate -- 20. 5-Fluorouracil -- 21. L-Asparaginase (Elspar/Erwinase) -- 22. Calcineurin Inhibitors -- 23. Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) -- PART IV: Anti-cancer Immunotherapy -- 25. Ipilimumab (MDX-010, Yervoy) -- 26. Bevacizumab (Avastin) -- 27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) -- PART V: Antiobiotics, Antiviral Agents, and Vaccines -- 28. Metronidazole (Flagyl) -- 29. Iodoform -- 30. Isoniazid -- 31. Highly Active Antiretroviral Therapy (HAART) -- 32. Vaccines -- PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents -- 33. Dilantin (Phenytoin Sodium) -- 34. Valproic Acid (Sodium Valproate, Depakote) -- 35. Vigabatrin (Sabril) -- 36. Lithium -- 37. Neuroleptics -- PART VII: Anesthetic and Sedative Agents -- 38. Barbiturates (Pentobarbital) -- 39. Nitrous Oxide (N2O) -- 40. Propofol -- PART VIII: Hemostatic and Vasoactive Agents -- 41. Embolic Agents -- 42. Aspirin and Plavix/Clopidogrel -- 43. Warfarin (Coumadin) -- 44. Heparin -- 45. Tissue Plasminogen Activator (tPA) -- 46. Oxidized Cellulose -- 47. Nasal Decongestants -- PART IX: Cardiovascular Support Agents -- 48. Supplemental Oxygen -- 49. Hypertonic Saline -- 50. Mannitol (1,2,3,4,5,6-Hexanehexol) -- 51. Triple H Therapy -- 52. Angiotensin Converting Enzyme (ACE) Inhibitors -- 53. Acetazolamide (Diamox) -- 54. Amiodarone -- PART X: Anti-inflammatory Agents -- 55. Acetominophen (Tylenol, Paracetamol) -- 56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals) -- 57. Synthetic Corticosteroids -- PART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs -- 58. Manganese in Total Parenteral Nutrition -- 59. Zinc Oxide (ZnO) -- 60. Insulin -- 61. Bisphosphonates -- 62. Recombinant Human Bone Morphogenetic Protein -- 63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid) -- 64. Topical Prostaglandin Analogues -- 65. Oral Contraceptives (Estrogen and Progestin) -- 66. Fish Oil -- PART XII: Injectable Filler Agents -- 67. Calcium hydroxyapatite-based Fillers -- 68. Hyaluronic Acid-based Fillers -- 69. Injectable Silicone Oil.
520 $a This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book’s closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike. .
650 0 $a Pharmacology. $3 583819
650 0 $a Radiology. $3 673943
700 1 $a Schaefer, Pamela Whitney. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1066756
700 1 $a Small, Juan E. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1066755
700 1 $a Ginat, Daniel Thomas. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1065369
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783031087738
776 0 8 $i Printed edition: $z 9783031087752
776 0 8 $i Printed edition: $z 9783031087769
856 4 0 $u https://doi.org/10.1007/978-3-031-08774-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)